If you don't already plan to do so, you should interview bob Nelson at ARCH venture partners. They are a top biotech VC and one of the few VCs that has been active in antivirals the last few years (confounded Vir Biotech which is working on covid among other things)

Bob has been on top of the crisis from the very beginning and has a lot of interesting insight